Glaxosmithkline Pharmaceuticals Ltd ISIN Code
Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
ISIN
Key Highlights
- The ISIN of Glaxosmithkline Pharmaceuticals Ltd is INE159A01016 as of 02 Feb 9.00 AM .
- The Latest Trading Price of Glaxosmithkline Pharmaceuticals Ltd is ₹ 2407 as of 01 Feb 15:30 .
Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
Share Price
Market Price of Glaxosmithkline Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 01 Feb 2026 | 2407.55 |
| 30 Jan 2026 | 2397.45 |
| 29 Jan 2026 | 2363.6 |
| 28 Jan 2026 | 2433.55 |
| 27 Jan 2026 | 2339.1 |
| 23 Jan 2026 | 2311.5 |
| 22 Jan 2026 | 2379.85 |
| 21 Jan 2026 | 2274.05 |
| 20 Jan 2026 | 2269.8 |
| 19 Jan 2026 | 2329.6 |
ISIN Codes For Similar Companies
| Company Name | |
|---|---|
| Cipla Ltd | INE059A01026 |
| Dr Reddys Laboratories Ltd | INE089A01031 |
| Torrent Pharmaceuticals Ltd | INE685A01028 |
| Sun Pharmaceutical Industries Ltd | INE044A01036 |
| Divis Laboratories Ltd | INE361B01024 |
Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd News Hub
Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter
Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju
Read more
05 Aug 24
GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore
Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju
Read more
03 Aug 24
GlaxoSmithKline Pharmaceuticals to conduct board meeting
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 M
Read more
19 Apr 25
GlaxoSmithKline Pharmaceuticals to declare Quarterly Result
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O
Read more
25 Oct 24
